Jonathan Young, COO of Akero Therapeutics ($AKRO), sold common shares on the open market 10 times over the past year, totaling about $2 million. His latest sale occurred on October 1, 2025. These transactions rank 3,489th out of 11,678 insiders in our database, trailing the average of $8.6 million across roughly 6 sales per insider. Young made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | D | Common Stock | 20000 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.02% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | D | Stock Option (Right to Buy) | 141205 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.17% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | D | Stock Option (Right to Buy) | 70279 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.09% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | D | Stock Option (Right to Buy) | 2328 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.00% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | D | Stock Option (Right to Buy) | 5032 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.01% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | D | Stock Option (Right to Buy) | 3421 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.00% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | D | Common Stock | 47573 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.06% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | D | Common Stock | 20000 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.02% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | D | Common Stock | 152616 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.19% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | D | Common Stock | 20000 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.02% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | D | Stock Option (Right to Buy) | 74053 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.09% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | D | Stock Option (Right to Buy) | 28584 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.03% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | D | Stock Option (Right to Buy) | 44982 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.05% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | D | Stock Option (Right to Buy) | 29074 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.04% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | D | Stock Option (Right to Buy) | 29073 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.04% |
| Dec. 9, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | D | Stock Option (Right to Buy) | 84051 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.10% |
| Nov. 24, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | M | Common Stock | 4284 | $21.09 | 261,182.0000 | 82,316,179 | 1.67% | 0.01% |
| Nov. 24, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | M | Common Stock | 3527 | $28.35 | 264,709.0000 | 82,316,179 | 1.35% | 0.00% |
| Nov. 24, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | M | Common Stock | 4739 | $21.10 | 269,448.0000 | 82,316,179 | 1.79% | 0.01% |
| Nov. 26, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | G | Common Stock | 9259 | $0.00 | 260,189.0000 | 82,316,179 | 3.44% | 0.01% |
| Nov. 24, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | M | Stock Option (Right to Buy) | 4284 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.01% |
| Nov. 24, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | M | Stock Option (Right to Buy) | 3527 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.00% |
| Nov. 24, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | M | Stock Option (Right to Buy) | 4739 | $0.00 | 0.0000 | 82,316,179 | 100.00% | 0.01% |
| Oct. 1, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 8299 | $47.64 | 261,099.0000 | 79,620,128 | 3.08% | 0.01% |
| Oct. 1, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | M | Stock Option (Right to Buy) | 12500 | $0.00 | 44,982.0000 | 79,620,128 | 21.75% | 0.02% |
| Oct. 1, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 4201 | $47.98 | 256,898.0000 | 79,620,128 | 1.61% | 0.01% |
| Oct. 1, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | M | Common Stock | 12500 | $21.10 | 269,398.0000 | 79,620,128 | 4.87% | 0.02% |
| Sept. 11, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 586 | $43.02 | 256,898.0000 | 79,620,128 | 0.23% | 0.00% |
| Sept. 2, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 61 | $47.58 | 257,484.0000 | 79,620,128 | 0.02% | 0.00% |
| Sept. 2, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 2739 | $47.14 | 257,545.0000 | 79,620,128 | 1.05% | 0.00% |
| Sept. 2, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | M | Common Stock | 12500 | $21.10 | 269,984.0000 | 79,620,128 | 4.85% | 0.02% |
| Sept. 2, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | M | Stock Option (Right to Buy) | 12500 | $0.00 | 57,482.0000 | 79,620,128 | 17.86% | 0.02% |
| Sept. 2, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 9700 | $45.78 | 260,284.0000 | 79,620,128 | 3.59% | 0.01% |
| Aug. 12, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | M | Common Stock | 12500 | $21.10 | 269,984.0000 | 79,620,128 | 4.85% | 0.02% |
| Aug. 12, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | M | Stock Option (Right to Buy) | 12500 | $0.00 | 69,982.0000 | 79,620,128 | 15.15% | 0.02% |
| Aug. 12, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 1349 | $48.32 | 257,484.0000 | 79,620,128 | 0.52% | 0.00% |
| Aug. 12, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 11151 | $47.72 | 258,833.0000 | 79,620,128 | 4.13% | 0.01% |
| June 30, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | A | Common Stock | 890 | $23.87 | 257,484.0000 | 79,620,128 | 0.35% | 0.00% |
| June 18, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 1453 | $54.84 | 256,594.0000 | 79,620,128 | 0.56% | 0.00% |
| June 10, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 2493 | $53.99 | 258,047.0000 | 79,620,128 | 0.96% | 0.00% |
| March 12, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 607 | $44.88 | 260,540.0000 | 79,620,128 | 0.23% | 0.00% |
| March 4, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 38553 | $45.07 | 261,147.0000 | 79,620,128 | 12.86% | 0.05% |
| March 4, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 11447 | $44.17 | 299,700.0000 | 79,620,128 | 3.68% | 0.01% |
| Feb. 3, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 4900 | $54.06 | 311,147.0000 | 0 | 1.55% | 0.00% |
| Feb. 3, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 5100 | $53.57 | 316,047.0000 | 0 | 1.59% | 0.00% |
| Jan. 24, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | M | Common Stock | 43064 | $6.36 | 321,147.0000 | 0 | 15.49% | 0.00% |
| Jan. 23, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | M | Stock Option (Right to Buy) | 43064 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 2, 2025 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 10000 | $28.03 | 278,083.0000 | 0 | 3.47% | 0.00% |
| Dec. 16, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | A | Common Stock | 24300 | $0.00 | 288,083.0000 | 0 | 9.21% | 0.00% |
| Dec. 16, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | A | Stock Option (Right to Buy) | 73700 | $0.00 | 73,700.0000 | 0 | 9999.99% | 0.00% |
| Dec. 10, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 2503 | $30.79 | 263,783.0000 | 0 | 0.94% | 0.00% |
| Dec. 2, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 10000 | $32.13 | 266,286.0000 | 0 | 3.62% | 0.00% |
| Nov. 1, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 292 | $32.94 | 276,286.0000 | 0 | 0.11% | 0.00% |
| Nov. 1, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | M | Common Stock | 40716 | $21.09 | 327,002.0000 | 0 | 14.22% | 0.00% |
| Nov. 1, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 34943 | $31.25 | 292,059.0000 | 0 | 10.69% | 0.00% |
| Nov. 1, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 15481 | $32.27 | 276,578.0000 | 0 | 5.30% | 0.00% |
| Nov. 1, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | M | Stock Option (Right to Buy) | 40716 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 14, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | M | Stock Option (Right to Buy) | 40000 | $0.00 | 40,716.0000 | 0 | 49.56% | 0.00% |
| Oct. 14, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 40000 | $30.15 | 286,286.0000 | 0 | 12.26% | 0.00% |
| Oct. 14, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | M | Common Stock | 40000 | $21.09 | 326,286.0000 | 0 | 13.97% | 0.00% |
| Oct. 1, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 10000 | $28.18 | 286,286.0000 | 0 | 3.38% | 0.00% |
| Sept. 10, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 568 | $26.18 | 296,286.0000 | 0 | 0.19% | 0.00% |
| Sept. 3, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 3710 | $26.42 | 298,144.0000 | 0 | 1.23% | 0.00% |
| Sept. 3, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 1290 | $27.58 | 296,854.0000 | 0 | 0.43% | 0.00% |
| Aug. 1, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 1969 | $27.23 | 301,854.0000 | 0 | 0.65% | 0.00% |
| Aug. 1, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 3031 | $26.44 | 303,823.0000 | 0 | 0.99% | 0.00% |
| July 1, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 5000 | $23.40 | 306,854.0000 | 0 | 1.60% | 0.00% |
| June 28, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | A | Common Stock | 1064 | $19.94 | 311,854.0000 | 0 | 0.34% | 0.00% |
| June 11, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 2516 | $22.64 | 310,790.0000 | 0 | 0.80% | 0.00% |
| June 3, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 5000 | $19.29 | 313,306.0000 | 0 | 1.57% | 0.00% |
| May 1, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 5000 | $20.15 | 318,306.0000 | 0 | 1.55% | 0.00% |
| April 1, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 4600 | $24.33 | 323,706.0000 | 0 | 1.40% | 0.00% |
| April 1, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stoek | 400 | $25.03 | 263,306.0000 | 0 | 0.15% | 0.00% |
| March 13, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | S | Common Stock | 651 | $28.33 | 328,306.0000 | 0 | 0.20% | 0.00% |
| March 1, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | M | Common Stock | 83321 | $0.62 | 328,957.0000 | 0 | 33.92% | 0.00% |
| March 1, 2024 | Akero Therapeutics, Inc. | $AKRO | Young Jonathan | Chief Operating Officer | M | Stock Option (Right to Buy) | 83321 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |